Janus Henderson Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,539
| Closed | -$417K | – | 2602 |
|
|
2024
Q1 | $417K | Buy |
26,539
+2
| +0% | +$31 | ﹤0.01% | 2091 |
|
|
2023
Q4 | $428K | Sell |
26,537
-90
| -0.3% | -$1.15K | ﹤0.01% | 2066 |
|
|
2023
Q3 | $338K | Buy |
26,627
+21
| +0.1% | +$290 | ﹤0.01% | 2136 |
|
|
2023
Q2 | $374K | Buy |
26,606
+15,102
| +131% | +$216K | ﹤0.01% | 2134 |
|
|
2023
Q1 | $178K | Buy |
+11,504
| New | +$192K | ﹤0.01% | 2521 |
|
|
2021
Q4 | – | Sell |
-407,237
| Closed | -$13.8M | – | 2600 |
|
|
2021
Q3 | $13.8M | Buy |
407,237
+109
| +0% | +$3.48K | 0.01% | 859 |
|
|
2021
Q2 | $14.9M | Sell |
407,128
-18,949
| -4% | -$734K | 0.01% | 857 |
|
|
2021
Q1 | $19.1M | Buy |
426,077
+91,239
| +27% | +$4.25M | 0.01% | 773 |
|
|
2020
Q4 | $19.1M | Sell |
334,838
-468
| -0.1% | -$27.7K | 0.01% | 758 |
|
|
2020
Q3 | $17.2M | Buy |
335,306
+304
| +0.1% | +$14.9K | 0.01% | 740 |
|
|
2020
Q2 | $20M | Sell |
335,002
-1,334
| -0.4% | -$71.4K | 0.01% | 696 |
|
|
2020
Q1 | $13.8M | Sell |
336,336
-461,888
| -58% | -$25.6M | 0.01% | 759 |
|
|
2019
Q4 | $49.7M | Sell |
798,224
-97,057
| -11% | -$4.61M | 0.03% | 595 |
|
|
2019
Q3 | $30.4M | Buy |
895,281
+219,574
| +32% | +$6.5M | 0.02% | 726 |
|
|
2019
Q2 | $15.2M | Buy |
675,707
+14,028
| +2% | +$328K | 0.01% | 854 |
|
|
2019
Q1 | $15.4M | Sell |
661,679
-40,817
| -6% | -$1.07M | 0.01% | 829 |
|
|
2018
Q4 | $14.7M | Buy |
702,496
+22,998
| +3% | +$565K | 0.01% | 827 |
|
|
2018
Q3 | $26.3M | Buy |
679,498
+120,683
| +22% | +$4.46M | 0.01% | 751 |
|
|
2018
Q2 | $22M | Buy |
+558,815
| New | +$16.4M | 0.01% | 778 |
|
Other funds holding DCPH
Janus Henderson Group's DCPH Position: Q2 2024 in Review
Janus Henderson Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 26,539 shares — an estimated $417K sold.
Janus Henderson Group first reported a position in DCPH in Q2 2018 and held it in 19 quarters. The position peaked at $49.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Janus Henderson Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Janus Henderson Group sold 26,539 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $417K.
- Janus Henderson Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 19 quarters.
- Janus Henderson Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $49.7M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.